Clinical Data Analytics Market 2028 By Deployment Model, Application, End User and Geography | The Insight Partners

report image

Clinical Data Analytics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Deployment Model (On-Premise, Cloud Based); Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and Compliance, Comparative Analytics/Comparative Effectiveness, Precision Health); End User (Pharmaceutical Companies, Healthcare Organizations, Research Organizations, Government Organizations) and Geography

Report Code: TIPRE00007603 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming


Clinical data analytics is a discipline that uses real-time medical data to, make decisions, develop insights. boost revenue, and reduce costs. Many organisations 've witnessed reduced medication errors, improved population health, and cost savings as a result of implementing clinical analytics. Clinical data analytics has greatly increased in recent years due to rapid improvements in key technologies and the widespread implementation of electronic health records (EHRs). There are numerous benefits of using clinical analytics techniques. It can aid in the reduction of administrative costs, the improvement of care coordination, the improvement of patient welfare, the provision of clinical decision support, and the prevention of fraud and abuse. It may also assist in cost reduction by eliminating differences in supply, overheads, and labour.


The Global Clinical Data Analytics Market Analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the clinical data analytics market with detailed market segmentation by deployment model, application and end user. The report provides key statistics on the market status of the leading clinical data analytics market players and offers key trends and opportunities in the market.


  •   Based on deployment model the market is segmented as, on-premise and cloud based.
  •   Based on application the market is segmented as, quality improvement and clinical benchmarking, clinical decision support, regulatory reporting and compliance, comparative analytics/comparative effectiveness and precision health.
  •   Based on end user the market is segmented as, pharmaceutical companies, healthcare organizations, research organizations and government organizations.


  •   Rising prevalence of cardiac disorders and other chronic disorders.
  •   Advancements in clinical data analytics is expected to spur the market growth.
  •   Rising adoption of EHRs and improved quality of care.
  •   Increasing healthcare expenditures is also expected to fuel the market growth.


  •   However, high cost of clinical data analytics solutions is expected to restrain market growth during the forecast period.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The clinical data analytics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the clinical data analytics market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the clinical data analytics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from clinical data analytics market are anticipated to lucrative growth opportunities in the future with the rising demand for Clinical data analytics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the clinical data analytics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Inspirata, Inc.
  •   CareEvolution, Inc.
  •   Cerner Corporation
  •   Health Catalyst
  •   IBM
  •   Koninklijke Philips N.V
  •   McKesson Corporation
  •   Optum, Inc.
  •   Allscripts Healthcare, LLC
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

2. Inspirata, Inc.
3. CareEvolution, Inc.
4. Cerner Corporation
5. Health Catalyst
6. IBM
7. Koninklijke Philips N.V
8. McKesson Corporation
9. Optum, Inc.
10. Allscripts Healthcare, LLC
11. Athenahealth, Inc
12. CitiusTech Inc
13. Inovalon
14. Oracle"
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount